Other Income / (Expense) Components:
Other Income / (Expense) for the three months ended March 31, 2024 consisted of net interest income of $154,000 and foreign exchange losses of ($30,000). For the three months ended March 31, 2023, Other Income / (Expense) consisted of net interest income of $4,000 and foreign exchange losses of $(57,000). The higher level of net interest income was reflective of higher cash balances in the 2024 period.
Income Tax Expense (Benefit):
Income tax expense (benefit) for the three months ended March 31, 2024 totaled ($121,000), representing an effective tax rate on our pre-tax loss of (42.9%), compared to $218,000 for the three months ended March 31, 2023, which represented a 45.6% effective tax rate on pre-tax income. The favorable effective tax rate in the 2024 period reflected a favorable adjustment to our tax valuation allowance related to the utilization of Singapore tax benefits.
Liquidity and Capital Resources:
Financial Conditions and Liquidity:
As of March 31, 2024, we had no bank debt, cash balances on hand, of $19.4 million and approximately $24.2 million of borrowing capacity under our existing credit facility.
Historically, we have funded our organic business needs with cash generated from operating activities. Controlling our operating working capital levels by closely managing our accounts receivable balance is an important element of cash generation. As of March 31, 2024, our accounts receivable “days sales outstanding” (“DSOs”) measurement was 56-days, which was 5 days lower than at March 31, 2023.
We believe that cash provided by operating activities, cash balances on hand and current availability under our credit facility will be adequate to fund our business needs and support our share repurchase program that we announced in February 2023 over the next twelve months, exclusive of any acquisition activity.
Cash flows provided by (used in) operating activities:
Cash (used in) operating activities for the three months ended March 31, 2024 totaled ($1.3 million), compared to $3.1 million provided during the three months ended March 31, 2023. Elements of cash flows in 2024 were a net loss of ($0.2 million), non-cash charges of $1.5 million, and an increase in operating working capital levels of ($2.6 million). Elements of cash flows in the 2023 period were net income of $0.3 million, non-cash charges of $1.6 million, and a decrease in operating working capital levels of $1.2 million. In the 2024 quarter, sequential revenue growth impacted operating working capital, particularly in our accounts receivable balances.
Cash flows (used in) investing activities:
Cash (used in) investing activities for the three months ended March 31, 2024 was ($278,000), compared to ($7,000) for the three months ended March 31, 2023. In the 2024 period, capital expenditures were responsible for our entire cash usage in investing activities. In the 2023 period, investing activities included $97,000 of capital expenditures, partially offset by $90,000 of deposit recoveries. The increase in capital expenditures in 2024, compared to 2023 reflects expenditures related to laptop purchases and other technology enhancements.
Cash flows provided by (used in) financing activities:
Cash (used in) financing activities for the three months ended March 31, 2024 totaled ($80,000) related to the repurchase of common stock under our share repurchase program. Cash (used in) financing activities for the three months ended March 31, 2023 totaled ($1.1 million) and consisted of our final term-loan debt repayment.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
23